Adverse	adverse	O	B_disease
effects	effects	O	I_disease
of	of	O	O
topical	topical	O	O
papaverine	papaverine	S_chemical	O
on	on	O	O
auditory	auditory	O	O
nerve	nerve	O	O
function	function	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
Papaverine	papaverine	S_chemical	O
hydrochloride	hydrochloride	O	O
is	is	O	O
a	a	O	O
direct-acting	direct-acting	O	O
vasodilator	vasodilator	O	O
used	used	O	O
to	to	O	O
manage	manage	O	O
vasospasm	vasospasm	O	S_disease
during	during	O	O
various	various	O	O
neurosurgical	neurosurgical	O	O
operations	operations	O	O
.	.	O	O

Transient	transient	O	B_disease
cranial	cranial	O	I_disease
nerve	nerve	O	I_disease
dysfunction	dysfunction	O	I_disease
has	has	O	O
been	been	O	O
described	described	O	O
in	in	O	O
a	a	O	O
few	few	O	O
cases	cases	O	O
with	with	O	O
topical	topical	O	O
papaverine	papaverine	S_chemical	O
.	.	O	O

This	this	O	O
study	study	O	O
supports	supports	O	O
previous	previous	O	O
reports	reports	O	O
and	and	O	O
provides	provides	O	O
neurophysiological	neurophysiological	O	O
evidence	evidence	O	O
of	of	O	O
an	an	O	O
adverse	adverse	O	O
effect	effect	O	O
on	on	O	O
the	the	O	O
auditory	auditory	O	O
nerve	nerve	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
We	we	O	O
conducted	conducted	O	O
a	a	O	O
retrospective	retrospective	O	O
review	review	O	O
of	of	O	O
70	70	O	O
consecutive	consecutive	O	O
microvascular	microvascular	O	O
decompression	decompression	O	O
operations	operations	O	O
and	and	O	O
studied	studied	O	O
those	those	O	O
patients	patients	O	O
who	who	O	O
received	received	O	O
topical	topical	O	O
papaverine	papaverine	S_chemical	O
for	for	O	O
vasospasm	vasospasm	O	S_disease
.	.	O	O

Topical	topical	O	O
papaverine	papaverine	S_chemical	O
was	was	O	O
used	used	O	O
as	as	O	O
a	a	O	O
direct	direct	O	O
therapeutic	therapeutic	O	O
action	action	O	O
to	to	O	O
manage	manage	O	O
vasospasm	vasospasm	O	S_disease
in	in	O	O
a	a	O	O
total	total	O	O
of	of	O	O
11	11	O	O
patients	patients	O	O
.	.	O	O

The	the	O	O
timing	timing	O	O
of	of	O	O
papaverine	papaverine	S_chemical	O
application	application	O	O
and	and	O	O
ongoing	ongoing	O	O
operative	operative	O	O
events	events	O	O
was	was	O	O
reviewed	reviewed	O	O
relative	relative	O	O
to	to	O	O
changes	changes	O	O
in	in	O	O
neurophysiological	neurophysiological	O	O
recordings	recordings	O	O
.	.	O	O

Brainstem	brainstem	O	O
auditory	auditory	O	O
evoked	evoked	O	O
potentials	potentials	O	O
(	(	O	O
BAEPs	baeps	O	O
)	)	O	O
were	were	O	O
routinely	routinely	O	O
used	used	O	O
to	to	O	O
monitor	monitor	O	O
cochlear	cochlear	O	O
nerve	nerve	O	O
function	function	O	O
during	during	O	O
these	these	O	O
operations	operations	O	O
.	.	O	O

FINDINGS	findings	O	O
:	:	O	O
A	a	O	O
temporal	temporal	O	O
relationship	relationship	O	O
was	was	O	O
found	found	O	O
between	between	O	O
topical	topical	O	O
papaverine	papaverine	S_chemical	O
and	and	O	O
BAEP	baep	O	O
changes	changes	O	O
leading	leading	O	O
to	to	O	O
complete	complete	O	O
waveform	waveform	O	O
loss	loss	O	O
.	.	O	O

The	the	O	O
average	average	O	O
temporal	temporal	O	O
delay	delay	O	O
between	between	O	O
papaverine	papaverine	S_chemical	O
and	and	O	O
the	the	O	O
onset	onset	O	B_disease
of	of	O	I_disease
an	an	O	O
adverse	adverse	O	O
BAEP	baep	O	O
change	change	O	O
was	was	O	O
5	5	O	O
min	min	O	O
.	.	O	O

In	in	O	O
10	10	O	O
of	of	O	O
11	11	O	O
patients	patients	O	O
,	,	O	O
BAEP	baep	O	O
waves	waves	O	O
II/III-V	ii/iii-v	O	O
completely	completely	O	O
disappeared	disappeared	O	O
within	within	O	O
2	2	O	O
to	to	O	O
25	25	O	O
min	min	O	O
after	after	O	O
papaverine	papaverine	S_chemical	O
.	.	O	O

Eight	eight	O	O
of	of	O	O
these	these	O	O
10	10	O	O
patients	patients	O	O
had	had	O	O
complete	complete	O	O
loss	loss	O	O
of	of	O	O
BAEP	baep	O	O
waveforms	waveforms	O	O
within	within	O	O
10	10	O	O
min	min	O	O
.	.	O	O

One	one	O	O
patient	patient	O	O
showed	showed	O	O
no	no	O	O
recovery	recovery	O	O
of	of	O	O
later	later	O	O
waves	waves	O	O
and	and	O	O
a	a	O	O
delayed	delayed	O	O
profound	profound	O	O
sensorineural	sensorineural	O	B_disease
hearing	hearing	O	B_disease
loss	loss	O	I_disease
.	.	O	O

The	the	O	O
average	average	O	O
recovery	recovery	O	O
time	time	O	O
of	of	O	O
BAEP	baep	O	O
waveforms	waveforms	O	O
to	to	O	O
pre-papaverine	pre-papaverine	S_chemical	O
baseline	baseline	O	O
values	values	O	O
was	was	O	O
39	39	O	O
min	min	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Topical	topical	O	O
papaverine	papaverine	S_chemical	O
for	for	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
vasospasm	vasospasm	O	S_disease
was	was	O	O
associated	associated	O	B_disease
with	with	O	I_disease
the	the	O	O
onset	onset	O	B_disease
of	of	O	I_disease
a	a	O	O
transient	transient	O	B_disease
disturbance	disturbance	O	I_disease
in	in	O	O
neurophysiological	neurophysiological	O	O
function	function	O	O
of	of	O	O
the	the	O	O
ascending	ascending	O	O
auditory	auditory	O	O
brainstem	brainstem	O	O
pathway	pathway	O	O
.	.	O	O

The	the	O	O
complete	complete	O	O
disappearance	disappearance	O	O
of	of	O	O
BAEP	baep	O	O
waveforms	waveforms	O	O
with	with	O	O
a	a	O	O
consistent	consistent	O	O
temporal	temporal	O	O
delay	delay	O	O
suggests	suggests	O	O
a	a	O	O
possible	possible	O	O
adverse	adverse	O	O
effect	effect	O	O
on	on	O	O
the	the	O	O
proximal	proximal	O	O
eighth	eighth	O	O
nerve	nerve	O	O
.	.	O	O

Recommendations	recommendations	O	O
to	to	O	O
avoid	avoid	O	O
potential	potential	O	O
cranial	cranial	O	B_disease
nerve	nerve	O	I_disease
deficits	deficits	O	I_disease
from	from	O	O
papaverine	papaverine	S_chemical	O
are	are	O	O
provided	provided	O	O
.	.	O	O

